Hypertension became the leading risk factor of death globally as well as in Bangladesh. Uncontrolled hypertension is the key challenge for the success of a hypertension control programs. According to the last national STEPS Survey in Bangladesh, hypertension control rate is only 11%. World Health Organization promoted the HEARTS technical package for the hypertension control programs to improve the control scenario. National Heart Foundation of Bangladesh is implementing a hypertension control program in selected Upazilas (sub-districts) of Bangladesh in collaboration with Non-Communicable Disease Control (NCDC) Program of Directorate General of Health Services (DGHS) and Resolve to Save Lives, USA. Proposed quasi experimental study will be conducted in collaboration with NCDC of DGHS, Resolve to Save Lives, USA and Johns Hopkins University, Baltimore with an objective of to evaluate the impact of HEARTS package on the rate of hypertension control in primary health care centers in Bangladesh. In this study equal number of hypertensive adult patients will be recruited in Upazila Health Complexes of control and intervention groups with a hypothesis of, implementation of HEARTS technical package in primary health care centers can reduce the blood pressure significantly. After obtaining informed written consent, respondents' basic demographic information, history of antihypertensive medication intake and related comorbidities will be taken. Blood pressure measurements data will be recorded also. All of these data will be collected via a secured mobile application, Simple App. Collected data will be preserved in a secured cloud based database. After six months of enrolment, and end-line data will be collected at the community setup, preferably at the home of respondents, following standard techniques of BP measurement by experienced Field Research Assistants. During whole of the study procedure, every ethical right of the participants will be preserved with an utmost priority. De-identified data will be shared with the partner organizations for further scientific analysis. This study will generate robust evidence for use of HEARTS technical packages in low-and middle-income countries, like Bangladesh, especially at low-level health facilities and provide guidance for designing and implementation of other hypertension control programs.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Enrollment
3,935
Components of WHO HEARTS technical package are 1. Universal BP screening via A\&D arm-in BP device. 2. Training of Medical Officers and Nurses on BP measurement using standard techniques. 3. Training of the nurses on screening, registration data collection via the Simple mobile smart-phone digital clinical hypertension information application. 4. Use of a drug and dose specific hypertension treatment protocol. 5. Standardized inventory and procurement practice to ensure a reliable supply of protocol medications. 6. Training and support for team-based model of hypertension care delivery. 7. Access to the Simple data dashboard for program monitoring. 8. Standardized procedure for patient follow-up. 9. Community-based prescription refilling.
Madarganj Upazila Health Complex
Jāmālpur, Dhaka Division, Bangladesh
Baniachang Upazila Health Complex
Habiganj, Bangladesh
Madhabpur Upazila Health Complex
Habiganj, Bangladesh
Bakhshiganj Upazila Health Complex
Jamalpur, Bangladesh
Dewanganj Upazila Health Complex
Jamalpur, Bangladesh
Islampur Upazila Health Complex
Jamalpur, Bangladesh
Melandaha Upazila Health Complex
Jamalpur, Bangladesh
Sarishabari Upazila Health Complex
Jamalpur, Bangladesh
Karimganj Upazila Health Complex
Kishoreganj, Bangladesh
Katiadi Upazila Health Complex
Kishoreganj, Bangladesh
...and 4 more locations
Difference in differences of systolic blood pressure (SBP)
defined as between- group difference in BP change at six months (BP change at six months calculated for each group as end-line minus baseline mean systolic BP)
Time frame: Six months
Difference in differences of diastolic blood pressure (DBP)
defined as between- group difference in BP change at six months (BP change at six months calculated for each group as end-line minus baseline mean diastolic BP)
Time frame: Six months
Difference in differences of rate of hypertension control.
defined (per UHC) as: NUMERATOR: Enrolled patients with controlled BP (SBP \<140 and DBP \<90 mmHg) measured in the community at six months/DENOMIN'ATOR: Total enrolled patients
Time frame: Six months
Rate of loss to follow-up.
defined (per UHC) as - NUMERATOR: Enrolled patients with no clinic visit in the 3 months previous to the six-month follow up/DENOMINATOR: Total enrolled patients
Time frame: Six months
Difference in differences of rate of hypertension control (Measured in the clinic)
defined (per UHC) as: NUMERATOR: Enrolled patients with controlled BP (SBP \<140 and DBP \<90 mmHg) at the most recent clinical visit within the 3 months previous to the six-month follow up/DENOMINATOR: Total enrolled patients
Time frame: Six months
Rate of loss to follow up
defined (per UHC) as: NUMERATOR: Enrolled patients with no clinic visit in the 3 months previous to the six-month follow up/DENOMINATOR: Total enrolled patients
Time frame: Six months
Difference in time to BP control
difference in time-to-control between arms based on follow-up in-clinic BP and assessed using the log-rank test
Time frame: Six months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.